HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide
Oxidative stress and inflammation are predominant features of several chronic diseases. The nuclear factor erythroid 2-related factor 2 (Nrf2) is a major arbiter in counteracting these insults via up-regulation of several defensive proteins, including heme oxygenase-1 (HO-1). HO-1-derived carbon mon...
Main Authors: | Roberto Motterlini, Aniket Nikam, Sylvie Manin, Anthony Ollivier, Jayne Louise Wilson, Sabrina Djouadi, Lucie Muchova, Thierry Martens, Michael Rivard, Roberta Foresti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Redox Biology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231718308693 |
Similar Items
-
Therapeutic effects of CO-releaser/Nrf2 activator hybrids (HYCOs) in the treatment of skin wound, psoriasis and multiple sclerosis
by: Zeina El Ali, et al.
Published: (2020-07-01) -
Increased Sirt1 secreted from visceral white adipose tissue is associated with improved glucose tolerance in obese Nrf2-deficient mice
by: Laura Braud, et al.
Published: (2021-01-01) -
Human and murine macrophages exhibit differential metabolic responses to lipopolysaccharide - A divergent role for glycolysis
by: Vijith Vijayan, et al.
Published: (2019-04-01) -
Releasing Nrf2 to promote neurite outgrowth
by: Chuanbin Yang, et al.
Published: (2015-01-01) -
Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway.
by: Ying Lu, et al.
Published: (2018-01-01)